This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Travel Medicine  • Infectious Diseases, Other  • Public Health  • World Health  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Otha Myles, MD; Glenn W. Wortmann, MD; James F. Cummings, MD; R. Vincent Barthel, MD, MPH; Sugat Patel, MD; Nancy F. Crum-Cianflone, MD, MPH; Nathan S. Negin, MD; Peter J. Weina, MD, PhD; Christian F. Ockenhouse, MD, PhD; Daniel J. Joyce, DO; Alan J. Magill, MD; Naomi E. Aronson, MD; Robert A. Gasser Jr, MD

Arch Intern Med. 2007;167(17):1899-1901.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

People who traveled to Central or Southwest Asia in support of Operation Enduring Freedom and Operation Iraqi Freedom may have been exposed to various diseases endemic to this region.¹ Some of these conditions have long incubation periods and may not present for weeks or months after travelers have returned to the United States. Among such diseases is visceral leishmaniasis (VL). Visceral leishmaniasis is a chronic systemic disease caused by parasites of the Leishmania donovani–Leishmania infantum complex. It is classically described as a syndrome of fever, progressive spleen and/or liver enlargement, weight loss, pancytopenia, and, if . . . [Full Text of this Article]

Methods


Results

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Positive rK39 Serologic Assay Results in US Servicemen with Cutaneous Leishmaniasis
Hartzell et al.
Am J Trop Med Hyg 2008;79:843-846.
ABSTRACT | FULL TEXT